DE69839553D1 - Verfahren zur herstellung von proteinen - Google Patents

Verfahren zur herstellung von proteinen

Info

Publication number
DE69839553D1
DE69839553D1 DE69839553T DE69839553T DE69839553D1 DE 69839553 D1 DE69839553 D1 DE 69839553D1 DE 69839553 T DE69839553 T DE 69839553T DE 69839553 T DE69839553 T DE 69839553T DE 69839553 D1 DE69839553 D1 DE 69839553D1
Authority
DE
Germany
Prior art keywords
methods
host cells
present
proteins
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69839553T
Other languages
English (en)
Inventor
Deb Chatterjee
Mary Longo
Elizabeth Flynn
Robert Oberfelder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Corp
Original Assignee
Invitrogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21877792&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69839553(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Invitrogen Corp filed Critical Invitrogen Corp
Application granted granted Critical
Publication of DE69839553D1 publication Critical patent/DE69839553D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/24—Extraction; Separation; Purification by electrochemical means
    • C07K1/26—Electrophoresis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13—Labelling of peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
DE69839553T 1997-01-08 1998-01-08 Verfahren zur herstellung von proteinen Expired - Lifetime DE69839553D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3465897P 1997-01-08 1997-01-08
PCT/US1998/000492 WO1998030684A1 (en) 1997-01-08 1998-01-08 Methods for production of proteins

Publications (1)

Publication Number Publication Date
DE69839553D1 true DE69839553D1 (de) 2008-07-10

Family

ID=21877792

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69839553T Expired - Lifetime DE69839553D1 (de) 1997-01-08 1998-01-08 Verfahren zur herstellung von proteinen

Country Status (8)

Country Link
US (8) US6703484B2 (de)
EP (3) EP0963435B1 (de)
JP (2) JP2001512306A (de)
AT (1) ATE397061T1 (de)
AU (1) AU6020998A (de)
DE (1) DE69839553D1 (de)
ES (1) ES2308800T3 (de)
WO (1) WO1998030684A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0963435B1 (de) 1997-01-08 2008-05-28 Invitrogen Corporation Verfahren zur herstellung von proteinen
JP3432158B2 (ja) * 1998-12-04 2003-08-04 日立ソフトウエアエンジニアリング株式会社 電気泳動方法、電気泳動装置及びそれに用いるマーカー試料
DK1133565T3 (da) 1999-07-02 2011-01-24 Morphosys Ag Generering af specifikke bindingspartnere til (poly)peptider, som der kodes for af genomiske DNA-fragmenter eller EST'er
US20030157720A1 (en) * 2002-02-06 2003-08-21 Expression Technologies Inc. Protein standard for estimating size and mass
EP1572720A4 (de) * 2002-05-24 2008-12-24 Nps Allelix Corp Verfahren zur enzymatischen herstellung von glp-2-(1-33)- und glp-2-(1-34)-peptiden
WO2003100022A2 (en) * 2002-05-24 2003-12-04 Restoragen, Inc. Methods and dna constructs for high yield production of polypeptides
WO2003100021A2 (en) 2002-05-24 2003-12-04 Restoragen, Inc. Methods and dna constructs for high yield production of polypeptides
DE10244502B4 (de) * 2002-09-25 2006-06-01 Universität Gesamthochschule Kassel Molekulargewichtsmarker für Proteine und Verfahren zu dessen Herstellung
WO2004035169A2 (en) * 2002-10-15 2004-04-29 The Regents Of The University Of Michigan Multidimensional protein separation system
WO2004072236A2 (en) * 2003-02-06 2004-08-26 The Board Of Trustees Of The University Of Illinois Methods and compositions for 3-d sodium dodecyl sulfate-polyacrylamide cube gel electrophoresis
EP1668146B1 (de) 2003-09-25 2014-11-12 Life Technologies Corporation Homogene populationen von molekülen
EP1704234B1 (de) * 2003-11-21 2012-01-18 NPS Pharmaceuticals, Inc. Herstellung von glucagonähnlichem peptid 2 und analogen
WO2005054548A2 (en) * 2003-11-28 2005-06-16 Invitrogen Corporation Methods, compositions, and kits for protein crystallization
WO2005114220A2 (en) * 2004-05-17 2005-12-01 Invitrogen Corporation Compositions, kits, and methods for calibration in mass spectrometry
WO2006037215A1 (en) * 2004-10-04 2006-04-13 National Research Council Of Canada Expression system, components thereof and methods of use
US7935788B2 (en) * 2004-10-04 2011-05-03 National Research Council Of Canada Reverse cumate repressor mutant
US7939331B2 (en) 2005-03-07 2011-05-10 Life Technologies Corporation Isotopically-labeled proteome standards
EP2069386A4 (de) * 2006-07-21 2009-10-28 Life Technologies Corp Proteinmolekülgewichtsstandards mit hoher trennschärfe
US7951559B2 (en) 2007-07-25 2011-05-31 E.I. Du Pont De Nemours And Company Recombinant peptide production using a cross-linkable solubility tag
GB0718012D0 (en) * 2007-09-14 2007-10-24 Lab901 Ltd Method for protein staining prior to electrophoresis
KR101016766B1 (ko) 2009-01-15 2011-02-25 한국과학기술연구원 티오레독신이 융합된 단백질 발현용 플라스미드 및 이를 이용한 목적 단백질의 생산방법
WO2011151721A1 (en) * 2010-06-04 2011-12-08 Lupin Limited Process for production of fusion proteins using truncated e. coli thioredoxin
WO2012149180A2 (en) 2011-04-26 2012-11-01 Life Technologies Corporation Fluorescent tracking dye
CN104471395B (zh) 2012-06-28 2017-05-03 生物辐射实验室股份有限公司 多重蛋白质定量标准物
CN105143860B (zh) 2013-03-14 2019-03-08 生物辐射实验室股份有限公司 蛋白质标准品
WO2016044619A1 (en) 2014-09-19 2016-03-24 Li-Cor, Inc. Multifunctional protein molecular weight ladders
EP3574001A1 (de) 2017-01-27 2019-12-04 Abera Bioscience AB Neue zusammensetzungen, verfahren und verwendungen

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980540A (en) 1975-03-28 1976-09-14 Hoefer Scientific Instruments Vertical gel slab electrophoresis apparatus and method
JPS5292590A (en) 1976-01-30 1977-08-04 Oriental Yeast Co Ltd Isoelectric point marker for separation of isoelectric points of gel
US4403036A (en) 1980-12-02 1983-09-06 University Of Iowa Research Foundation Genetic reagents for generating plasmids containing multiple copies of DNA segments
US4405720A (en) * 1981-03-04 1983-09-20 The United States Of America As Represented By The Department Of Health And Human Services Silver stains for protein in gels
US4507233A (en) 1981-04-22 1985-03-26 Oriental Yeast Co., Ltd. Colored molecular weight marker
US4499782A (en) 1981-10-05 1985-02-19 National Research Development Corporation Transmission units of the toroidal race rolling friction type
US4468466A (en) 1982-02-16 1984-08-28 The United States Of America As Represented By The Department Of Health And Human Services Silver stains for protein in gels--a modified procedure
SE8300693L (sv) 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US5279792A (en) 1984-06-22 1994-01-18 Janssen Pharmaceutica N.V. Staining kit for proteins and nucleic acids
GB8415998D0 (en) * 1984-06-22 1984-07-25 Janssen Pharmaceutica Nv Staining method
US4575452A (en) 1984-09-21 1986-03-11 E. I. Du Pont De Nemours And Company Kit for silver staining proteins and nucleic acids
US4791069A (en) 1984-09-21 1988-12-13 Ortho Diagnostic Systems Inc. Methods for attaching ligands or anti-ligands to a solid phase
US4569794A (en) 1984-12-05 1986-02-11 Eli Lilly And Company Process for purifying proteins and compounds useful in such process
SE459503B (sv) 1985-05-03 1989-07-10 Excorim Kommanditbolag Hybrid-dna-molekyl innefattande dna-sekvens som kodar foer protein g samt foerfarande foer framstaellning av protein g
US4766224A (en) * 1985-08-19 1988-08-23 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
US4677196A (en) 1985-09-06 1987-06-30 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
US5082773A (en) 1986-02-14 1992-01-21 Pharmacia Lkb Biotechnology Ab Cloned streptococcal genes encoding protein G and their use to construct recombinant microorganisms to produce protein G
US4782027A (en) 1987-01-22 1988-11-01 President And Fellows Of Harvard College Protein detection by negative staining
US5643758A (en) 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
US5215896A (en) * 1987-03-20 1993-06-01 Creative Biomolecules, Inc. Leader sequences for the production of recombinant proteins
AU601273B2 (en) 1987-03-20 1990-09-06 Creative Biomolecules, Inc. Leader sequences for the production of recombinant proteins
US6150503A (en) 1988-10-28 2000-11-21 Pestka Biomedical Laboratories, Inc. Phosphorylated fusion proteins
EP0647713B1 (de) 1989-07-19 1998-05-13 Tonen Corporation Peptidyl prolyl-cis.trans-isomersae
US5594115A (en) 1990-04-09 1997-01-14 Pharmacia & Upjohn Company Process of purifying recombinant proteins and compounds useful in such process
US5316908A (en) 1990-07-13 1994-05-31 Life Technologies, Inc. Size markers for electrophoretic analysis of DNA
US5595887A (en) 1990-07-16 1997-01-21 Bionebraska, Inc. Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment
US5132439A (en) * 1990-11-19 1992-07-21 Promega Corporation Protein staining compositions and methods
US5273906A (en) * 1990-11-19 1993-12-28 Promega Corporation Protein staining compositions and methods
US5714326A (en) 1991-01-24 1998-02-03 Dawson; Elliott P. Method for the multiplexed preparation of nucleic acid molecular weight markers and resultant products
US5292646A (en) 1991-02-06 1994-03-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US5270181A (en) * 1991-02-06 1993-12-14 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
JPH04271800A (ja) 1991-02-28 1992-09-28 Hitachi Ltd 電気泳動装置
US5139630A (en) 1991-05-31 1992-08-18 Beckman Instruments, Inc. Identification of sample constituents utilizing capillary electrophoresis
US6060296A (en) 1991-07-03 2000-05-09 The Salk Institute For Biological Studies Protein kinases
DE69230061T2 (de) 1991-07-25 2000-01-05 Oriental Yeast Co Ltd Künstliches immunoglobulin-bindendes protein
ES2225819T3 (es) 1991-09-20 2005-03-16 Amgen Inc. Factor neurotrofico de origen glial.
CA2125037C (en) 1991-11-14 2001-02-20 Jonathan Stamler Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality
EP0635025B1 (de) 1992-04-07 2002-11-06 The Scripps Research Institute Verfahren zur herstellung modifizierten proteine
US5439812A (en) 1992-04-08 1995-08-08 The Pennsylvania Research Corporation Antibodies catalyzing deamidation of proteins
US5705649A (en) * 1992-07-20 1998-01-06 Promega Corporation Protein staining compositions and methods
WO1994003072A1 (en) 1992-07-31 1994-02-17 Panlabs Incorporated Recombinant cells, dna constructs, vectors and methods for expressing phytate degrading enzymes in desired ratios
US5605691A (en) * 1992-09-17 1997-02-25 Ophidian Pharmaceuticals, Inc. Immunologically active proteins from inclusion bodies
US5834247A (en) 1992-12-09 1998-11-10 New England Biolabs, Inc. Modified proteins comprising controllable intervening protein sequences or their elements methods of producing same and methods for purification of a target protein comprised by a modified protein
KR100260632B1 (ko) 1992-12-28 2000-07-01 성재갑 이식형 소마토트로핀 조성물
US5801005A (en) 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US5480971A (en) 1993-06-17 1996-01-02 Houghten Pharmaceuticals, Inc. Peralkylated oligopeptide mixtures
EP0725821B1 (de) 1993-10-28 1998-07-15 Life Technologies, Inc. Nukleinsäure-längenstandard zur abschätzung des masse
US6680378B1 (en) 1993-10-28 2004-01-20 Invitrogen Corporation Nucleic acid marker ladder for estimating mass
US5449758A (en) 1993-12-02 1995-09-12 Life Technologies, Inc. Protein size marker ladder
ATE529444T1 (de) 1994-01-11 2011-11-15 Dyax Corp Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten
US5578180A (en) 1994-03-31 1996-11-26 Novel Experimental Technology System for PH-neutral longlife precast electrophoresis gel
US5643722A (en) 1994-05-11 1997-07-01 Trustees Of Boston University Methods for the detection and isolation of proteins
US5891993A (en) 1994-08-11 1999-04-06 The Scripps Research Institute Template assembled synthetic protein
US5541087A (en) 1994-09-14 1996-07-30 Fuji Immunopharmaceuticals Corporation Expression and export technology of proteins as immunofusins
EP0796335A1 (de) 1994-12-07 1997-09-24 Bionebraska, Inc. Herstellung von peptiden mittles rekombinanter fusionsprotein-konstruktionen
EP0744614B1 (de) 1995-03-31 1999-12-22 Laboratory of Molecular Biophotonics Anwendung von isoelektrischen Punkt Markern bei der isoelektrischen Fokussierung mit Fluoreszenzdetektierung
US5698521A (en) 1995-04-04 1997-12-16 Zymogenetics, Inc. Native calcitonin mimetics
US6379516B1 (en) 1995-04-26 2002-04-30 Ethrog Biotechnology Ltd. Apparatus and method for electrophoresis
US5582702A (en) 1995-04-26 1996-12-10 Ethrog Biotechnology Ltd. Apparatus and method for electrophoresis
US6184344B1 (en) 1995-05-04 2001-02-06 The Scripps Research Institute Synthesis of proteins by native chemical ligation
EP0832096B1 (de) 1995-05-04 2001-07-18 The Scripps Research Institute Proteinsynthese mittels nativer chemischer ligation (07.01.97)
US5616502A (en) 1995-05-19 1997-04-01 Molecular Probes, Inc. Non-specific protein staining using merocyanine dyes
US6143557A (en) 1995-06-07 2000-11-07 Life Technologies, Inc. Recombination cloning using engineered recombination sites
AU724922B2 (en) 1995-06-07 2000-10-05 Invitrogen Corporation Recombinational cloning using engineered recombination sites
US6274369B1 (en) 1996-02-02 2001-08-14 Invitrogen Corporation Method capable of increasing competency of bacterial cell transformation
US6307018B1 (en) 1996-12-24 2001-10-23 The Scripps Research Institute General chemical ligation
EP0963435B1 (de) 1997-01-08 2008-05-28 Invitrogen Corporation Verfahren zur herstellung von proteinen
US5917012A (en) 1997-04-03 1999-06-29 Wako Pure Chemical Industries, Ltd. Peptide derivatives
DE19729248C1 (de) 1997-07-09 1998-07-09 Jochen Uhlenkueken Standardprotein
AU8403298A (en) 1997-07-15 1999-02-10 Life Technologies, Inc. Nucleic acid ladders
US6057106A (en) 1998-01-23 2000-05-02 Novex Sample buffer and methods for high resolution gel electrophoresis of denatured nucleic acids
US6013165A (en) 1998-05-22 2000-01-11 Lynx Therapeutics, Inc. Electrophoresis apparatus and method
US6251651B1 (en) 1998-06-04 2001-06-26 Amano Pharmaceutical Co., Ltd. Protein-deamidating enzyme, gene encoding the same, production process therefor, and use thereof
US6800287B2 (en) 1998-09-25 2004-10-05 Yeda Research And Development Co., Ltd. Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
AU6608500A (en) 1999-07-27 2001-02-13 Bio-Rad Laboratories, Inc. Automated landmarking for two-dimensional electrophoresis
US6436703B1 (en) 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
US20020155455A1 (en) 2000-08-11 2002-10-24 Invitrogen Corporation Highly homogeneous molecular markers for electrophoresis
US6562213B1 (en) 2000-08-30 2003-05-13 Ethrog Biotechnology Ltd. Electrophoresis apparatus for simultaneous loading of multiple samples
EP1377527A4 (de) 2001-03-08 2004-09-15 Ethrog Biotechnology Ltd Vorrichtung und verfahren zur elektrophorese
ATE445454T1 (de) 2001-05-10 2009-10-15 Life Technologies Corp Verfahren und vorrichtungen zur elektrophorese von vorgegossenen, hydratisierbaren trennmedien
US7183116B2 (en) 2001-05-14 2007-02-27 The Institute For Systems Biology Methods for isolation and labeling of sample molecules
US20030232014A1 (en) 2002-03-01 2003-12-18 Mds Proteomics Inc. Phosphorylated proteins and uses related thereto
US7084929B2 (en) 2002-07-29 2006-08-01 Koninklijke Philips Electronics N.V. Video data filtering arrangement and method
EP1668146B1 (de) 2003-09-25 2014-11-12 Life Technologies Corporation Homogene populationen von molekülen
WO2006138366A2 (en) 2005-06-16 2006-12-28 New England Biolabs, Inc. Protein markers
EP2069386A4 (de) 2006-07-21 2009-10-28 Life Technologies Corp Proteinmolekülgewichtsstandards mit hoher trennschärfe

Also Published As

Publication number Publication date
US6703484B2 (en) 2004-03-09
JP2008119000A (ja) 2008-05-29
US8012715B2 (en) 2011-09-06
US7259242B2 (en) 2007-08-21
EP0963435B1 (de) 2008-05-28
US8519099B2 (en) 2013-08-27
US20020065392A1 (en) 2002-05-30
EP0963435A1 (de) 1999-12-15
US7223566B2 (en) 2007-05-29
ATE397061T1 (de) 2008-06-15
ES2308800T3 (es) 2008-12-01
US20060286633A1 (en) 2006-12-21
US20110108420A1 (en) 2011-05-12
EP2336313A1 (de) 2011-06-22
EP0963435A4 (de) 2004-09-22
JP4791436B2 (ja) 2011-10-12
US20070184527A1 (en) 2007-08-09
US7265206B2 (en) 2007-09-04
US9409942B2 (en) 2016-08-09
WO1998030684A1 (en) 1998-07-16
JP2001512306A (ja) 2001-08-21
US20140097086A1 (en) 2014-04-10
AU6020998A (en) 1998-08-03
US20040204563A1 (en) 2004-10-14
US20070190606A1 (en) 2007-08-16
US20060269992A1 (en) 2006-11-30
EP2196536A1 (de) 2010-06-16
US8389681B2 (en) 2013-03-05

Similar Documents

Publication Publication Date Title
DE69839553D1 (de) Verfahren zur herstellung von proteinen
WO1999055868A3 (en) Fizz proteins
CY1112334T1 (el) Ομολογα πολυπεπτιδια il-17 και θεραπευτικες χρησεις αυτων
IL193149A0 (en) Il-17c homologous polypeptides and therapeutic uses thereof
WO2005071088A3 (en) Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof
DE60021318D1 (de) Verfahren zur Herstellung von natürlich gefalteten Proteinen durch Co-Sekretion von molekularen Chaperonen
DK1294876T3 (da) EV-VEGF-nukleinsyrer og -polypeptider samt fremgangsmåder til deres benyttelse
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
DK1616878T3 (da) Udskilte og membranspændende polypeptider samt nukleinsyrer kodende for disse
DE69028499T2 (de) Neues Verfahren zur Produktion von nichtfusioniertem Protein in E. coli
DE69634757D1 (de) Vektor zur expression von n-terminal verlängerten proteinen in hefezellen
DE69031996T2 (de) Menschlicher rekombinanter plazentaler ribonuklease-inhibitor und verfahren zur herstellung
WO2000043419A3 (en) Exocytosis pathway proteins and methods of use
EP0688224A4 (de) Ein mutiertes protein und verfahren und materialien zu seiner herstellung und verwendung
ATE353969T1 (de) Expressionsvektoren, transformierte wirtszellen und fermentationsverfahren zur herstellung rekombinanter polypeptide
EP1434483A4 (de) Für nukleinsäuren codierende, miteinander verbundene chromo/fluoreszenzdomänen und verfahren zu ihrer verwendung
ATE415422T1 (de) Menschliches gas-6 (growth arrest-specific gene 6) protein und dafür kodierende nukleinsäuren
ATE335005T1 (de) Menschliches protein mit in vitro antiproliferativer aktivität.
ATE380864T1 (de) Menschliches prostasin-ähnliches protein und dafür kodierende nukleinsäure
DK1241180T3 (da) Humant A33 antigen-lignende protein og nucleinsyrer, der koder for dette
DK1241184T3 (da) Humant synaptogyrin-lignende protein og nukleinsyrer kodende for dette
DK1241183T3 (da) Humant HCAR-agtig protein og nucleinsyrer kodende derfor
EP1241185A3 (de) Menschliches Protocadherin-ähnliches Protein und dafür kodierende Nukleinsäure
ATE268819T1 (de) Pro241 polypeptide und dafür kodierende nukleinsäuren
DK1249491T3 (da) Nucleinsyre, der opformeres i humane tumorer samt beslægtede materialer og fremgangsmåder

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: LIFE TECHNOLOGIES CORP. (N.D.GES.D. STAATES DE, US